Some Ebola Patients Should Get Placebo in Drug Tests: FDA
Created 11/05/2014 - 12:51
- Edward Cox, director of the FDA’s Office of Antimicrobial Products, said Wednesday that some patients with Ebola need to forgo potentially life-saving treatments so researchers can see how they fare compared to those who receive the experimental drugs, Bloomberg reported.
- Cox noted that randomised studies would be "challenging," but they are necessary and would compare "the best supportive care versus the best supportive care with a drug."
- He added that the FDA has a meeting next week to hear from companies, which he did not disclose, producing experimental treatments, adding that "those products are out there in the news."
- Cox said that in order to speed up the search for the best drug, the agency is planning to check on effectiveness at "multiple intervals" during the studies.